Q-omics provides the consensus-scored MIR1273C profile across patient tissues and cancer cell-line models. MIR1273C expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, MIR1273C is differentially expressed in 5, with the highest sampling consensus in READ. Additionally, MIR1273C RNA expression shows 11,243 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KIRC, READ, and TGCT as cancer lineages where MIR1273C shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR1273C — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR1273C survival associations across molecular data types. MIR1273C RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR1273C RNA expression–survival associations across cancer types. High MIR1273C expression shows unfavorable associations in ACC, LIHC, SKCM, READ and ESCA, but favorable associations in KIRC. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .006). Together, the overview and detailed table identify KIRC as the clearest survival context for MIR1273C RNA expression.
This table summarizes MIR1273C tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR1273C. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR1273C shows lower tumor expression in THCA, LUSC and KIRC and higher tumor expression in READ and STAD. The READ box plot shows higher MIR1273C RNA expression in tumor versus normal tissue (log2 FC = +0.880, t-test p < 0.001).
This table shows molecular features associated with MIR1273C in patient tissues and cancer cell lines. In patient samples, MIR1273C shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
